Arcanobacterium haemolyticum: PCR Detection and Clinical Overview

Arcanobacterium haemolyticum belongs to the genus Arcanobacterium and is a Gram-positive, slender rod-shaped bacterium with rounded ends. It is typically observed as single cells or arranged in short chains under microscopic examination.

The organism is non-spore-forming and non-motile, lacking flagella. Gram staining reveals a positive reaction, consistent with its cell wall structure.

Biochemically, it ferments carbohydrates such as glucose and maltose, producing acid without gas formation. It is catalase negative, oxidase negative, indole negative, and nitrate reduction positive, providing a characteristic biochemical profile for identification.

Arcanobacterium haemolyticum is primarily associated with human hosts and may colonize skin and mucosal surfaces. It is considered an opportunistic pathogen, with infection typically occurring when host defenses are compromised.

Transmission is believed to occur through direct contact, particularly via skin or mucosal disruption. Individuals with poor hygiene, skin injuries, or weakened immune systems are at increased risk of infection.

Arcanobacterium haemolyticum is commonly associated with pharyngitis, particularly in adolescents and young adults. It may also cause skin and soft tissue infections, including wound infections and cellulitis.

In immunocompromised individuals, more severe infections may occur, although they are relatively uncommon. Clinical symptoms may include sore throat, fever, localized inflammation, and skin lesions.

Arcanobacterium haemolyticum grows best under anaerobic or microaerophilic conditions with 5–10% CO₂ at temperatures of 35–37°C. On blood agar, colonies typically appear after 48–72 hours as small (0.5–1 mm), round, convex, gray-white colonies with clear beta-hemolysis.

Conventional identification relies on colony morphology and biochemical testing; however, differentiation from similar organisms can be challenging.

Molecular methods such as PCR and real-time qPCR provide rapid, sensitive, and specific detection of Arcanobacterium haemolyticum, improving diagnostic accuracy and supporting clinical and research applications.

Prevention of Arcanobacterium haemolyticum infection focuses on maintaining good personal hygiene and proper wound care to prevent bacterial entry through damaged skin or mucosal surfaces.

Enhancing host immunity through balanced nutrition, regular exercise, and adequate rest is essential in reducing infection risk, particularly in vulnerable populations.

Special attention should be given to immunocompromised individuals, including the elderly, children, and patients undergoing immunosuppressive therapy. Early recognition of symptoms and timely medical intervention are critical for effective management.